SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-005685
Filing Date
2022-03-01
Accepted
2022-03-01 08:30:25
Documents
16
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39825
2 ex99-1.htm EX-99.1 43674
3 ex99-1_001.jpg GRAPHIC 25445
4 ex99-1_002.jpg GRAPHIC 2793
  Complete submission text file 0001493152-22-005685.txt   335651

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vynt-20220301.xsd EX-101.SCH 3033
6 XBRL DEFINITION FILE vynt-20220301_def.xml EX-101.DEF 26452
7 XBRL LABEL FILE vynt-20220301_lab.xml EX-101.LAB 34476
8 XBRL PRESENTATION FILE vynt-20220301_pre.xml EX-101.PRE 22595
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3705
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 22694155
SIC: 8071 Services-Medical Laboratories